Inventor · disambiguated record
Leonid Beigelman
Also filed as: BEIGELMAN LEONID · BEIGELMAN LEONID D
224 granted patents·170 pending applications·9,294 citations·filing 1994–2025
99Inventor score
Files withSIRNA THERAPEUTICS INC126ALIOS BIOPHARMA INC54RIBOZYME PHARM INC45ALIGOS THERAPEUTICS INC41JANSSEN BIOPHARMA INC28
Top patents by PatentIndex Score
394 records- 0199US10000754B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Jun 19, 2018·35 cites·21 claims
- 0299US9771588B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·44 cites·52 claims
- 0399US9732344B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2016·Granted Aug 15, 2017·43 cites·29 claims
- 0499US9657294B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted May 23, 2017·36 cites·23 claims
- 0599US9249174B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2013·Granted Feb 2, 2016·79 cites·7 claims
- 0699US9181551B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·102 cites·82 claims
- 0799US8202979B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acidMCSWIGGEN JAMES·Filed 2003·Granted Jun 19, 2012·106 cites·9 claims
- 0899US7176304B2RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)MCSWIGGEN JAMES·Filed 2004·Granted Feb 13, 2007·187 cites·2 claims
- 0999US5627053A2'deoxy-2'-alkylnucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 1995·Granted May 6, 1997·1.5k cites·5 claims
- 1098US9603864B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2015·Granted Mar 28, 2017·56 cites·48 claims
- 1198US9603863B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2015·Granted Mar 28, 2017·42 cites·25 claims
- 1298US9243022B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2013·Granted Jan 26, 2016·72 cites·8 claims
- 1398US9073960B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2012·Granted Jul 7, 2015·33 cites·40 claims
- 1498US8980865B2Substituted nucleotide analogsALIOS BIOPHARMA INC·Filed 2012·Granted Mar 17, 2015·95 cites·24 claims
- 1598US8772474B2Cyclic nucleotide analogsBEIGELMAN LEONID·Filed 2011·Granted Jul 8, 2014·76 cites·43 claims
- 1698US8618277B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)BEIGELMAN LEONID·Filed 2012·Granted Dec 31, 2013·87 cites·4 claims
- 1798US8273866B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)MCSWIGGEN JAMES·Filed 2003·Granted Sep 25, 2012·100 cites·12 claims
- 1898US8268986B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)BEIGELMAN LEONID·Filed 2011·Granted Sep 18, 2012·54 cites·5 claims
- 1998US8188247B2Conjugates and compositions for cellular deliveryBEIGELMAN LEONID·Filed 2010·Granted May 29, 2012·36 cites·3 claims
- 2098US7989612B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Granted Aug 2, 2011·36 cites·10 claims
- 2198US7923547B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Granted Apr 12, 2011·82 cites·3 claims
- 2298US7109165B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2002·Granted Sep 19, 2006·90 cites·74 claims
- 2398US6673611B2Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionSIRNA THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·218 cites·17 claims
- 2498US6362323B1Non-nucleotide containing nucleic acidRIBOZYME PHARM INC·Filed 2000·Granted Mar 26, 2002·179 cites·7 claims
- 2598US6117657ANon-nucleotide containing enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1998·Granted Sep 12, 2000·253 cites·13 claims
- 2698US5998203AEnzymatic nucleic acids containing 5'-and/or 3'-cap structuresRIBOZYME PHARM INC·Filed 1996·Granted Dec 7, 1999·784 cites·41 claims
- 2798US5716824A2'-O-alkylthioalkyl and 2-C-alkylthioalkyl-containing enzymatic nucleic acids (ribozymes)RIBOZYME PHARM INC·Filed 1995·Granted Feb 10, 1998·373 cites·12 claims
- 2897US11851422B2Anti-viral compoundsALIGOS THERAPEUTICS INC·Filed 2022·Granted Dec 26, 2023·8 cites·61 claims
- 2997US10307439B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2017·Granted Jun 4, 2019·21 cites·63 claims
- 3097US10112966B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2016·Granted Oct 30, 2018·13 cites·9 claims
- 3197US9605018B2Substituted nucleotide analogsALIOS BIOPHARMA INC·Filed 2015·Granted Mar 28, 2017·47 cites·20 claims
- 3297US9278990B2Substituted nucleotide analogsALIOS BIOPHARMA INC·Filed 2014·Granted Mar 8, 2016·60 cites·31 claims
- 3397US8242257B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)BEIGELMAN LEONID·Filed 2011·Granted Aug 14, 2012·29 cites·5 claims
- 3497US7956176B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Granted Jun 7, 2011·42 cites·14 claims
- 3597US7858625B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2005·Granted Dec 28, 2010·22 cites·2 claims
- 3697US6849726B2Non-nucleotide containing RNASIRNA THERAPEUTICS INC·Filed 2003·Granted Feb 1, 2005·129 cites·12 claims
- 3797US6602858B2Nucleic acid catalysts comprising L-nucleotide analogsRIBOZYME PHARM INC·Filed 2001·Granted Aug 5, 2003·68 cites·23 claims
- 3897US6395713B1Compositions for the delivery of negatively charged moleculesRIBOZYME PHARM INC·Filed 1998·Granted May 28, 2002·367 cites·13 claims
- 3997US6248878B1Nucleoside analogsRIBOZYME PHARM INC·Filed 1997·Granted Jun 19, 2001·264 cites·16 claims
- 4096US10144755B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2016·Granted Dec 4, 2018·10 cites·3 claims
- 4196US9758544B2Substituted nucleosides, nucleotides and analogs thereofALIOS BIOPHARMA INC·Filed 2015·Granted Sep 12, 2017·20 cites·54 claims
- 4296US8895723B2Methods of preparing substituted nucleotide analogsALIOS BIOPHARMA INC·Filed 2013·Granted Nov 25, 2014·44 cites·20 claims
- 4396US8877731B2Azido nucleosides and nucleotide analogsBEIGELMAN LEONID·Filed 2011·Granted Nov 4, 2014·70 cites·30 claims
- 4496US8871737B2Substituted nucleotide analogsSMITH DAVID BERNARD·Filed 2011·Granted Oct 28, 2014·131 cites·65 claims
- 4596US8236944B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)BEIGELMAN LEONID·Filed 2011·Granted Aug 7, 2012·21 cites·5 claims
- 4696US7728013B2Method of modulating stress-activated protein kinase systemINTERMUNE INC·Filed 2006·Granted Jun 1, 2010·40 cites·19 claims
- 4796US6649751B2Synthesis, deprotection, analysis and purification of RNA and ribozymesSIRNA THERAPEUTICS INC·Filed 2002·Granted Nov 18, 2003·68 cites·184 claims
- 4896US6617438B1Oligoribonucleotides with enzymatic activitySIRNA THERAPEUTICS INC·Filed 1999·Granted Sep 9, 2003·312 cites·27 claims
- 4996US6528640B1Synthetic ribonucleic acids with RNAse activityRIBOZYME PHARM INC·Filed 1999·Granted Mar 4, 2003·283 cites·3 claims
- 5096US6469158B1Synthesis, deprotection, analysis and purification of RNA and ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Oct 22, 2002·205 cites·17 claims
Showing the top 50 of 394 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Leonid Beigelman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →